Sansure Biotech Inc (688289) — Working Capital to Net Assets Ratio
Sansure Biotech Inc (688289) has a Working Capital to Net Assets ratio of 54.6% as of March 2026. Working capital of CN¥3.95 Billion (current assets of CN¥5.16 Billion minus current liabilities of CN¥1.21 Billion) is measured against net assets of CN¥7.23 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See how many days can Sansure Biotech Inc fund operations to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Sansure Biotech Inc Working Capital to Net Assets (2017–2025)
This chart shows how Sansure Biotech Inc's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of March 2026, the ratio stands at 54.6%, reflecting working capital of CN¥3.95 Billion against net assets of CN¥7.23 Billion CNY. For the complete balance sheet picture, see Sansure Biotech Inc (688289) total assets.
Annual Working Capital to Net Assets for Sansure Biotech Inc (2017–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Sansure Biotech Inc from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check how resilient are Sansure Biotech Inc's assets to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 24.3% | CN¥4.07 Billion | CN¥16.75 Billion | CN¥5.27 Billion | CN¥1.21 Billion | ▼ -44.2 pp |
| 2024 | 68.5% | CN¥5.03 Billion | CN¥7.35 Billion | CN¥5.79 Billion | CN¥754.80 Million | ▲ +0.8 pp |
| 2023 | 67.8% | CN¥5.03 Billion | CN¥7.42 Billion | CN¥5.95 Billion | CN¥919.15 Million | ▼ -11.5 pp |
| 2022 | 79.2% | CN¥5.95 Billion | CN¥7.51 Billion | CN¥7.53 Billion | CN¥1.57 Billion | ▼ -3.8 pp |
| 2021 | 83.1% | CN¥5.30 Billion | CN¥6.38 Billion | CN¥5.97 Billion | CN¥663.93 Million | ▼ -9.5 pp |
| 2020 | 92.6% | CN¥4.39 Billion | CN¥4.75 Billion | CN¥5.08 Billion | CN¥688.69 Million | ▲ +27.3 pp |
| 2019 | 65.3% | CN¥363.84 Million | CN¥557.48 Million | CN¥437.20 Million | CN¥73.36 Million | ▲ +11.3 pp |
| 2018 | 54.0% | CN¥213.93 Million | CN¥396.29 Million | CN¥359.11 Million | CN¥145.18 Million | ▲ +1.9 pp |
| 2017 | 52.1% | CN¥197.50 Million | CN¥378.99 Million | CN¥318.43 Million | CN¥120.92 Million | — |